Agilent Technologies recently announced the appointment of two new business unit presidents and the company's business structure to provide better service to its customers. The company appointed Patrick Kaltenbach as Senior Vice President of Agilent and President of Life Sciences and Applied Markets Group (LSAG). This business group was formed by the merger of the former chemical analysis group and the life science group. After the merger, most of Agilent's instruments and software will be unified into this organization management. This will better serve the analytical laboratories in the field. At the same time, the company appointed Jacob Thaysen as President of Agilent's Senior Vice President and Diagnostics and Genomics Group (DGG). This new business group, comprised of the Diagnostics and Genes business unit, will serve the diverse needs of clinical laboratories. The above two appointments will take effect immediately. Fred Strohmeier, president of the Life Sciences and Diagnostics Group (LDG), announced that he will retire in the second quarter of fiscal 2015. He will serve as a company consultant from now until retirement. Mike McMullen, President and Chief Operating Officer and Chief Executive Officer of Agilent, said: "I would like to thank Fred for his contribution to the company for more than 35 years. With his many years of experience in life sciences, Fred recently gave Agilent a leadership in the field of diagnostics. I wish him all the best in his retirement." Mike McMullen also said: "The company announced organizational restructuring to provide services to customers in a fast, efficient and unified voice. The business combination is not about technology but around the market, and the adjusted organizational structure will buy customers for themselves. The products, software and services required provide a more convenient and direct route. "I am very pleased that Patrick and Jacob have been elected presidents of two business groups. They are mature leaders with far-sighted and extraordinary customer insights across our entire business. This high-quality management team is also established. Marking another big step for Agilent's efforts to seize growth opportunities," adds Mike McMullen. About Patrick Kaltenbach Kaltenbach is the President of the LSAG Group and is responsible for leading the Agilent Life Sciences and Applied Chemistry market. Prior to his current position, Kaltenbach served as Vice President and General Manager of Life Sciences Products and Solutions for Agilent, where he was responsible for the strategic direction and development of all Agilent Life Sciences products. In 1991, Kaltenbach joined Agilent's predecessor, Hewlett-Packard Co., as a research and development engineer in the capillary electrophoresis business unit. He has held various management positions in the R&D department and has held senior management positions for many years. Kaltenbach holds a degree in Precision Engineering from the University of Applied Sciences in Karlsruhe, Germany. About Jacob Thaysen Thaysen is the President of DGG Group and is responsible for the strategic direction and day-to-day management of Agilent's diagnostic and genetic business. Prior to his current position, Thaysen served as Vice President of the Company and General Manager of the Diagnostics and Genes Business of Agilent's former Life Sciences and Diagnostics Division. He is responsible for the overall operations of the business, including strategic direction, project management, sales, marketing and R&D. In 2012, after Agilent acquired Dako, Thaysen, an employee of the original Dako company, entered Agilent. He served as vice president of research and development at Dako, and previously served as a corporate management consultant for Copenhagen Consulting (now Quartz+Co). Earlier, he worked for Cantion. In this research and defense application development company, he served as the company's founding partner and chief technology officer. Thaysen holds a Ph.D. in Physics from the Technical University of Denmark. Kaltenbach and Thaysen will be based at Agilent's headquarters office in Santa Clara, California. New quarterly financial statements Starting in the first quarter of fiscal 2015, Agilent's financial statements will be based on statistics and announcements from three business groups: Life Sciences and Applications Markets Group (LSAG), Diagnostics and Gene Group (DGG), and Agilent CrossLab Group (ACG). . ACG was announced in September and is led by Mark Doak, responsible for Agilent's service and consumables business. We are the only hemp manufacturer that integrates planting, processing, sales and transportation, so that we can guarantee 100% traceability of every customer's order. As the world's leading producer and supplier of hemp food ingredients, we have obtained many international food certificates, including HACCP, Organic Certificate, BRC, Kosher, Halal, etc. Quality and food safety have been favored by European and American customers. So far, we have achieved comprehensive cooperation with distributors in Europe and America, and the export volume has ranked first. Industrial hemp,organic hemp protein,organic hemp oil,organic hemp hearts Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com